Skip to main content

FDA Found Anaerobic Bacteria in Sealed Tattoo Inks

The presence of microbes in tattoo inks raises concerns regarding the products’ safety.  

Written byShelby Bradford, PhD
| 3 min read
Photograph of the end of a tattoo gun and pots of different colored ink on a napkin.
Register for free to listen to this article
Listen with Speechify
0:00
3:00

Tattoos are a longstanding form of self-expression through body art but given their nature of breaking the skin to deposit ink, the safety of the products that parlors use is imperative. While temporary inflammation is normal, in 2012, the Food and Drug Administration (FDA) helped investigate a series of reported severe rashes in people after a tattoo application. The cause turned out to be an ink contaminated with a species of non-tuberculosis mycobacteria (NTM).1 These and other incidences led to product recalls predominantly due to microbial contamination.2

“As a result of that, we started to look into what did we need to do from a regulatory perspective to make sure that these products were safe and being safely used,” said Linda Katz, the director for the Office of Cosmetics and Colors at the FDA, which regulates tattoo and permanent makeup inks.

In their follow up studies, Katz and others from the agency identified contamination with aerobic bacteria in one-third of all the inks assessed between 2015 and 2019.3-5 In a recent study, Katz and her colleagues expanded their investigation to assess contamination with anaerobic microbes. The team identified anaerobic bacteria in addition to aerobic microbes in several tattoo and permanent makeup inks.6 The findings, published in Applied Environmental Microbiology, highlight the need for continued monitoring to ensure the products’ safety.

Continue reading below...

Like this story? Sign up for FREE Immunology updates:

Latest science news storiesTopic-tailored resources and eventsCustomized newsletter content
Subscribe

“When you think about tattoo pigment, which is meant to be [in] a place where it probably doesn't belong forever, if there is contamination, especially with an anaerobe versus an aerobe…anaerobes are much harder for our immune system to combat,” said Adam Friedman, a dermatologist at George Washington University who was not involved with the study. “What's unique about it is that they don't just focus on [NTM] which is usually what the spotlight’s on. They're actually looking at a range of bacteria, both aerobic and anaerobic,” said Friedman.

For their experiments, the FDA scientists sampled 75 different inks from multiple manufacturers that sold products in the United States by swabbing culture plates for growth in aerobic, anaerobic, and low oxygen conditions. They recovered bacteria from 26 inks. Most products only contained one isolate, although some contained two.

The researchers performed 16S ribosomal RNA to identify the species responsible for the ink contamination. They identified 22 distinct species across all the contaminated products, including two anaerobic species. Eight species are potential pathogens. The most common taxa overall were Staphylococcus species, and all were considered potential pathogens.

“Because of the continued presence that we've been finding of microbial contamination, we're continuing to inspect and to look at these products further,” Katz said. According to the researchers, the recovery of microbes from tattoo and permanent makeup inks, some of which were labeled sterile, prompts further study into the manufacturers’ sterilization methods.

“We need to ensure that those receiving [tattoos] are safe and those who are doing [tattoos] are also safe in the sense of they are not put in potentially liability harm’s way in terms of using contaminated ink,” Friedman said. “This is a very long-standing industry that really deserves the appropriate quality assurance.”

Add The Scientist as a preferred source on Google

Add The Scientist as a preferred Google source to see more of our trusted coverage.

Meet the Author

  • Shelby Bradford, PhD

    Shelby is an Associate Editor at The Scientist. She earned her PhD in immunology and microbial pathogenesis from West Virginia University, where she studied neonatal responses to vaccination. She completed an AAAS Mass Media Fellowship at StateImpact Pennsylvania, and her writing has also appeared in Massive Science. Shelby participated in the 2023 flagship ComSciCon and volunteered with science outreach programs and Carnegie Science Center during graduate school. 

    View Full Profile

Related Topics

You might also be interested in...
Loading Next Article...
You might also be interested in...
Loading Next Article...
The Scientist October Digest cover
October 2026

Antarctica’s Blood Falls Teems With Mysterious Microbial Life

Miles away from the closest ocean, marine microbes thrive in the red ice and mud around Blood Falls, offering clues to microbial adaptation and past climate events.

View this Issue
Find better biologics faster with Stunner and the AI Developability Workcell

Find better biologics faster with Stunner and the AI Developability Workcell

Unchained Labs
An image of microcentrifuge tubes arranged within colorful laboratory racks.

Choose clarity. Choose speed. Choose MyMass™

Refeyn
Characterizing LNP Heterogeneity With Super-Resolution Imaging

Characterizing LNP Heterogeneity With Super-Resolution Imaging

Oni
Conceptual multicolored image of DNA helices.

Exploring the Most Impactful CRISPR Stories

Promega

Products

A monoclonal antibody surrounded by immune cells and red blood cells

CellRaft AIR: Find the Right Antibody-Producing Cells Faster

Cell Microsystems
Maxwell® Rapid ccfDNA Kit

Maxwell® Rapid ccfDNA Kit: Automated Purification of ccfDNA in Under 30 Minutes

Promega
Leica Biosystems, Tempus, and Paige logos side by side, marking the addition of Paige digital pathology AI tools to the Aperio AI Store.

Oncology Researchers Gain AI Cancer Tools in One Platform

Beckman Coulter Life Sciences Logo

Beckman Coulter Life Sciences Launches Vi-CELL BLU 2.0 Software to Advance Data Integrity and GMP Readiness in Cell Analysis